Analysis-Europe Faces Long Wait for Weight-Loss Drugs as Governments Eye Costs

By Ludwig Burger and Andreas Rinke FRANKFURT (Reuters) – Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month, its third European market, but only people who pay from their own pocket or have certain private health insurance plans will be able to get it. A …